Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Fundamentals
Mkt Cap
$509.85M
Volume
-
52W High
$15.50
52W Low
$6.87
PE Ratio
-
Avg. Volume
405,548.38
EPS (Annual)
-$0.9874
P/B
1.30
Rev/Employee
-
Earnings
Nov 12
32
Bearish Sentiment
How do you feel about ETRA?
openmarketalerts
$ETRA — Director Orbimed Advisors LLC bought $745K of stock from Nov 6 to Nov 10. 92,116 shares.
2
AlertsAndNews
$ETRA Insider action here
Electra Therapeutics Form 4, Insider Buy
Carl L. Gordon (Director, 10%+ Reporting Person) Reports 92,116 Shares Bought @ $8.08 Avg., totaling approximately $744,297 through OrbiMed-related funds.
1
openmarketalerts
$ETRA: $3.6M of stock bought by Director Orbimed Advisors LLC from Nov 3 to Nov 5. 472,571 shares.
1
Link your Stocktwits account
Ask your agent for live sentiment, watchers, trending tickers, and news.